TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round - BusinessWire - Wed Mar 3, 7:00AM CST
BusinessWire - CMTX
Wed Mar 3, 7:00AM CST
TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NYSE: LH). These strategic investments enable further transformation of TrakCel's cellular therapy orchestration solution, growth of its existing partner ecosystem, and continued global expansion.
Walgreens to Make Pixel by Labcorp(TM) COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide - BusinessWire - Wed Feb 24, 12:00PM CST
BusinessWire - CMTX
Wed Feb 24, 12:00PM CST
As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp(TM) to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas.
Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio - GlobeNewswire - Tue Feb 23, 8:15AM CST
GlobeNewswire - CMTX
Tue Feb 23, 8:15AM CST
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced an expansion of its collaboration with Labcorp (NYSE:LH), a leading global life sciences company, to enable broader access to Adaptive's growing portfolio of immune-driven clinical diagnostic and research products. The expanded collaboration includes a commercial agreement for Adaptive's clonoSEQ and immunoSEQ assays and a lab services agreement for Adaptive's recently launched T-Detect COVID(TM) test, the first clinical T-cell based test for patients to confirm recent or prior COVID-19 infection.